Comprehensive Notes: Genpact Capital Structure, IG Bond Market Trends, and NQDC Hedging Strategies

Genpact Capital Structure and Financing Strategy

Existing Indebtedness: * Term Loan: Genpact has an outstanding term loan of just north of $400,000,000$ , which is due for maturity next year. * Bonds: The company has a bond maturity due in a few years, but it is not a near-term obligation.
Historical Financing Strategy: * Genpact typically issues short-dated tenors on new issues, usually favoring a $5$ -year term. * Transaction sizes traditionally range between $300,000,000$ and $400,000,000$ .
Capital Management Objectives: * Leverage: The company is currently operating well below its leverage limits. * Market Access: The primary concern for management is maintaining access to capital markets rather than managing leverage levels specifically. * Refinancing Philosophy: There is a desire to address the near-term term loan sooner rather than later to manage potential market headwinds and provide financial "optionality."

Investment Grade (IG) Bond Market Dynamics and Headwinds

General Market Sentiment: * The market is in a volatile period following the Iranian conflict, but the IG bond market has remained surprisingly constructive. * Credit Spreads: The IG bond index is at $78$ basis points, which is only $5$ basis points off the all-time tights dating back to the year $2000$ .
Market Strength Drivers: * Fundamentals: IG companies show strong earnings, no significant missed projections, stable leverage, and minimal downgrades. * Technicals: Massive fund inflows. This week alone saw approximately $7,000,000,000$ in fund flows into the IG asset class, one of the largest weekly inflows recorded.
Issuance Supply Statistics: * Corporate supply is currently running $58\%$ ahead of the five-year average. * Jumbo Deals: Notable high-volume deals include Amazon ( $37,000,000,000$ ), Oracle ( $25,000,000,000$ ), Meta ( $25,000,000,000$ on a recent Thursday), and Salesforce ( $25,000,000,000$ ).

Case Studies in High-Profile Debt Issuance

Concentrix (February Deal): * Target: Originally sought a three, seven, and potentially ten-year deal for $800,000,000$ to refinance a bond maturing this year. * Outcome: Due to market feedback, the deal was downsized and shortened to a $600,000,000$ three-year bond only. * Pricing: Spread was Treasuries plus $300$ basis points. The new issue concession was roughly $75$ basis points relative to outstandings. * Investor Concerns: Investors pushed back significantly because Concentrix continued share buybacks despite being on a negative outlook at credit agencies (Low $BBB$ range).
Salesforce: * Purpose: To fund the largest Accelerated Share Repurchase (ASR) of all time, representing $14\%$ of their market cap. * Investor Feedback: Despite being rated mid-to-high Single-A, the bond was priced at levels more consistent with a $BBB$ rating. * Headwinds: Investors were wary of the use of proceeds for buybacks and potential business disruption from Artificial Intelligence (AI). There were concerns that Salesforce might return in $6$ months for another $25,000,000,000$ to further buy back shares, dropping their rating to $BBB$ .
ADP: * Strategy: Issued a $1,000,000,000$ deal for incremental share repurchases. * Success Factor: Unlike Salesforce, ADP was highly "scripted" and committed to maintaining their current credit ratings, which provided enough comfort for investors to proceed despite similar sector headwinds.
DXC (Failed Deal): * Context: Attempted a deal last year on the same day as Genpact's previous issuance. The trade failed after a day of marketing ("busted"). * Resolution: DXC eventually raised money in the Euro market with a significant premium and coupon steps. The failed dollar deal is viewed as a "black eye" in the IG bond market.

Data Center Financing Structures

Theme: Acquisition finance is active, particularly in healthcare, but Data Center/Hyperscaler borrowing is the dominant story.
Unique Structure (RD Michigan/Blackstone): * Deal Size: $14,000,000,000$ . * Mechanism: The deal was technically for a developer called Related (non-IG), but was backstopped by lease payments from Oracle (IG). * Credit Quality: Because Oracle is on the hook for lease payments even if the center isn't completed (starting in two years), the rating agencies view this as Oracle risk rather than developer risk. * Market Scope: There have been $5$ or $6$ similar transactions ranging from $4,000,000,000$ to $27,000,000,000$ (the latter backed by Meta late last year).

Genpact Specific Pricing and Execution Analysis

Indicative Pricing (as of meeting date): * $5$ -Year Yield: Showing at Treasuries plus $155$ basis points, resulting in a yield of approximately $5.6\%$ . * Historical Comparison: A comparable deal in November last year was priced at $135$ basis points over Treasuries with a $4.95\%$ yield.
Execution Strategy: * Management emphasizes the need for "optimal messaging" regarding AI and commitment to IG ratings. * During the previous marketing cycle, management noted they were asked about AI far more frequently ( $10$ + times) than credit ratings (only $2$ times). * Follow-up: A formal check-in is planned for "summer proper" (July).

Non-Qualified Deferred Compensation (NQDC) Hedging Solutions

Overview of NQDC Plans: * Offered by over $90\%$ of Fortune 500 companies. * Standard practice is for the plan's investment options to mirror the company's $401(k)$ offerings (e.g., S&P 500).
Genpact's Current Setup: * Genpact currently uses Corporate Owned Life Insurance (COLI) as a hedge. * Approximate value of $75,000,000$ held in a Rabbi Trust.
Identified Problems: * Accounting Volatility: Mark-to-market changes in the COLI assets create "noise" in the "Other Income" line of the P&L because it is not effectively offset by the liability movement. * Illiquidity: Capital is tied up in the trust and is not accessible until a specific death event or trigger occurs.
Four Strategic Hedging Options: 1. Unhedged: No assets purchased; Genpact effectively bets against the market. If the s&p 500 rises $20\%$ , the company incurs a $20\%$ loss on the liability. 2. Physical Hedge: Genpact buys the actual securities. This creates an accounting mismatch because liabilities are "above the line" (G&A) and assets are "below the line" (Other Income). 3. COLI (Current): Taxes are deferred, but capital is illiquid, expenses are often non-transparent, and it does not fix the P&L mismatch. 4. Total Return Swap (TRS): The preferred recommendation from Bank of America.

Deep Dive: Total Return Swap (TRS) for NQDC

Accounting Benefit (ASC 16): Allows the company to collapse the mark-to-market noise, effectively netting the asset and liability movements within the same P&L line (G&A).
Financial Efficiency: * Unfunded: Does not require the full outlay of $75,000,000$ . * Cost: Financing fee is typically sub- $5\%$ (SOFR plus a spread), which is significantly lower than a corporation's Weighted Average Cost of Capital (WACC).
Implementation Strategy: * Reallocation: Genpact would keep the COLI but reallocate the underlying funds to a low-volatility/short-duration fixed-income strategy. * The Swap: Execute the TRS to mirror the actual plan performance. If the reallocation yields more than the swap cost, the company generates a net P&L benefit. * Tax Advantage: Gains on the swap are generally deferred until benefit payments are made to participants.
Client Context: IBM is cited as a major company that transitioned from a COLI-only strategy to including a TRS after facing similar funding and volatility issues.

Questions & Discussion

Question (Management): Does the reallocation of COLI trigger a P&L event?
Response (Banker): No, the reallocation from mirroring the plan to a low-volatility strategy should not trigger a P&L event.
Question (Management): What is the perceived downside to TRS?
Response (Banker): Historically, the biggest hurdles are administrative overhead and the illiquidity of existing Rabbi Trusts. The bank offers an administrative service to manage this.
Question (Management): Is funding a priority for the Rabbi Trust?
Response (Management): Yes, continuing to put money into the trust would likely remain a priority for the company.
Action Item: The Bank of America team will provide a quantitative P&L and cash flow analysis. Management will review this and potentially pre-clear the transaction with their auditors at KPMG.